Clinical Trial Update: Evaluation of a New Ebola Vaccine Using a Short-interval Prime-boost Vaccination [Phase 1]

View source ↗

Summary

This update reports a Phase 1 evaluation of a new Ebola vaccine using a short-interval prime-boost, with the trial status marked as completed and results posted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ebola Virus Disease

Snippet

Sponsor: University of Oxford | Conditions: Ebola Virus Disease | Phase 1 | Status: COMPLETED | Results posted: 2019-02-06